Chemotherapy resistance in lung cancer
ES Kim - Lung Cancer and Personalized Medicine: Current …, 2016 - Springer
Despite a growing interest in development of non-cytotoxic targeted agents, systemic
chemotherapy is still the mainstay of treatment for both non-small cell lung cancer (NSCLC) …
chemotherapy is still the mainstay of treatment for both non-small cell lung cancer (NSCLC) …
Chemotherapy Resistance in Lung Cancer.
ES Kim - Advances in Experimental Medicine and Biology, 2016 - europepmc.org
Despite a growing interest in development of non-cytotoxic targeted agents, systemic
chemotherapy is still the mainstay of treatment for both non-small cell lung cancer (NSCLC) …
chemotherapy is still the mainstay of treatment for both non-small cell lung cancer (NSCLC) …
[引用][C] Chemotherapy Resistance in Lung Cancer
ES Kim - Lung Cancer and Personalized Medicine, 2015 - cir.nii.ac.jp
Chemotherapy Resistance in Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
Chemotherapy Resistance in Lung Cancer
ES Kim - Advances in experimental medicine and biology, 2016 - pubmed.ncbi.nlm.nih.gov
Despite a growing interest in development of non-cytotoxic targeted agents, systemic
chemotherapy is still the mainstay of treatment for both non-small cell lung cancer (NSCLC) …
chemotherapy is still the mainstay of treatment for both non-small cell lung cancer (NSCLC) …
Chemotherapy Resistance in Lung Cancer
ES Kim - Lung Cancer and Personalized Medicine: Current …, 2015 - books.google.com
Despite a growing interest in development of non-cytotoxic targeted agents, systemic
chemotherapy is still the mainstay of treatment for both non-small cell lung cancer (NSCLC) …
chemotherapy is still the mainstay of treatment for both non-small cell lung cancer (NSCLC) …
Chemotherapy Resistance in Lung Cancer
ES Kim - Springer
Despite a growing interest in development of non-cytotoxic targeted agents, systemic
chemotherapy is still the mainstay of treatment for both non-small cell lung cancer (NSCLC) …
chemotherapy is still the mainstay of treatment for both non-small cell lung cancer (NSCLC) …